Jeffrey Swensen

12.9k total citations · 2 hit papers
87 papers, 3.1k citations indexed

About

Jeffrey Swensen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jeffrey Swensen has authored 87 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 29 papers in Molecular Biology and 28 papers in Cancer Research. Recurrent topics in Jeffrey Swensen's work include Cancer Genomics and Diagnostics (25 papers), Genetic factors in colorectal cancer (18 papers) and Lung Cancer Treatments and Mutations (10 papers). Jeffrey Swensen is often cited by papers focused on Cancer Genomics and Diagnostics (25 papers), Genetic factors in colorectal cancer (18 papers) and Lung Cancer Treatments and Mutations (10 papers). Jeffrey Swensen collaborates with scholars based in United States, Qatar and Bosnia and Herzegovina. Jeffrey Swensen's co-authors include Zoran Gatalica, Joanne Xiu, Semir Vranić, Mark H. Skolnick, David E. Goldgar, David Spetzler, Amy B. Heimberger, Rebecca Feldman, John de Groot and Shouhao Zhou and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Jeffrey Swensen

86 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular characterization of cancers with NTRK gene fusions

2018 345 citations Zoran Gatalica, Joanne Xiu et al. profile →
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

2017 308 citations Joanne Xiu, Zoran Gatalica et al. profile →

Peers

Jeffrey Swensen

ONCOL

GENET

PFM

Michel Longy France

Roland P. Kuiper Netherlands

Shashikant Kulkarni United States

Bjarni A. Agnarsson Iceland

Olivier Caron France

Ludmila Gorunova Norway

Socorro Marıá Rodríguez-Pinilla Spain

Cristina E. Tognon United States

Gavin Ha United States

Stephen Baylin United States

Michel Longy France

Jeffrey Swensen

1.3k ×1.0

ONCOL

2.4k ×2.0

940 ×1.2

GENET

864 ×1.1

1.0k ×1.4

PFM

Citations per year, relative to Jeffrey Swensen Jeffrey Swensen (= 1×) peers Michel Longy

Countries citing papers authored by Jeffrey Swensen

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Swensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Swensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Swensen more than expected).

Fields of papers citing papers by Jeffrey Swensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Swensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Swensen. The network helps show where Jeffrey Swensen may publish in the future.

Co-authorship network of co-authors of Jeffrey Swensen

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Swensen. A scholar is included among the top collaborators of Jeffrey Swensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Swensen. Jeffrey Swensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ribeiro, Jennifer R., Todd Maney, Stephanie Rock, et al.. (2025). GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling. Cancer Research Communications. 5(9). 1477–1489. 1 indexed citations

Andrake, Mark, Pilar Mur, Joanne Xiu, et al.. (2024). Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity. Cancer Research Communications. 4(1). 213–225. 6 indexed citations

Nagasaka, Misako, Yasmine Baca, Joanne Xiu, et al.. (2023). Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset. Translational Oncology. 36. 101744–101744. 13 indexed citations

Darabi, Sourat, Andrew Elliott, Jia Zeng, et al.. (2022). Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions. Cancers. 14(6). 1505–1505. 4 indexed citations

Darabi, Sourat, Joanne Xiu, Benedito A. Carneiro, et al.. (2022). BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina. 58(12). 1818–1818. 10 indexed citations

Krušlin, Božo, Zoran Gatalica, Ondřej Hes, et al.. (2021). TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors. Clinical Genitourinary Cancer. 19(4). 333–338. 14 indexed citations

Prieto‐Granada, Carlos, Diana Morlote, Peter Pavlidakey, et al.. (2021). Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1‐rearranged adnexal skin tumors. Journal of Cutaneous Pathology. 48(9). 1139–1149. 26 indexed citations

Vranić, Semir, Phillip Stafford, Juan Palazzo, et al.. (2020). Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers. Clinical Breast Cancer. 20(4). 326–331.e1. 28 indexed citations

Ou, Sai‐Hong Ignatius, Joanne Xiu, Misako Nagasaka, et al.. (2020). Identification of Novel CDH1-NRG2α and F11R-NRG2α Fusions in NSCLC Plus Additional Novel NRG2α Fusions in Other Solid Tumors by Whole Transcriptome Sequencing. JTO Clinical and Research Reports. 2(2). 100132–100132. 6 indexed citations

10.

Jonna, Sushma, Rebecca Feldman, Jeffrey Swensen, et al.. (2019). Detection of NRG1 Gene Fusions in Solid Tumors. Clinical Cancer Research. 25(16). 4966–4972. 155 indexed citations

11.

Gatalica, Zoran, Semir Vranić, Phillip Stafford, et al.. (2019). Spindle cell carcinoma of the breast: Rare cancer with potentially targetable biomarkers. Annals of Oncology. 30. iii19–iii19. 1 indexed citations

12.

Stevens, Todd M., Diana Morlote, Jeffrey Swensen, et al.. (2018). Malignant Ewing-Like Neoplasm With an EWSR1-KLF15 Fusion: At the Crossroads of a Myoepithelial Carcinoma and a Ewing-Like Sarcoma. A Case Report With Treatment Options. International Journal of Surgical Pathology. 26(5). 440–447. 12 indexed citations

13.

Stevens, Todd M., Diana Morlote, Jeffrey Swensen, et al.. (2018). Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study. Head and Neck Pathology. 13(2). 162–168. 8 indexed citations

14.

Torabi, Alireza, et al.. (2017). Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature. Pathology. 49(4). 447–450. 9 indexed citations

15.

Arguello, David, et al.. (2016). P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC). Journal of Thoracic Oncology. 11(10). S221–S221. 1 indexed citations

16.

Sumner, Kelli, Jeffrey Swensen, Melinda Procter, et al.. (2014). Noncontinuously Binding Loop-Out Primers for Avoiding Problematic DNA Sequences in PCR and Sanger Sequencing. Journal of Molecular Diagnostics. 16(5). 477–480. 3 indexed citations

17.

Melis, Roberta, Tracy R. Lewis, Alison Millson, et al.. (2012). Copy Number Variation and Incomplete Linkage Disequilibrium Interfere with the HCP5 Genotyping Assay for Abacavir Hypersensitivity. Genetic Testing and Molecular Biomarkers. 16(9). 1111–1114. 13 indexed citations

18.

Svensson, Annika, Lan-Szu Chou, Christine E. Miller, et al.. (2010). Detection of Large Rearrangements in the Cystic Fibrosis Transmembrane Conductance Regulator Gene by Multiplex Ligation-Dependent Probe Amplification Assay When Sequencing Fails to Detect Two Disease-Causing Mutations. Genetic Testing and Molecular Biomarkers. 14(2). 171–174. 11 indexed citations

19.

Swensen, Jeffrey. (1997). Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Human Molecular Genetics. 6(9). 1513–1517. 97 indexed citations

20.

Neuhausen, Susan L., Teresa Gilewski, Larry Norton, et al.. (1996). Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genetics. 13(1). 126–128. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact